Paper Details
- Home
- Paper Details
Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
Author: McCarthyPhilip L, OlsonKatherine A, WestKathleen
Original Abstract of the Article :
Tacrolimus, a macrolide immunosuppressant, is used topically for the treatment of cutaneous manifestations of graft-versus-host disease (GVHD) for rapid, symptomatic relief of pruritus and erythema. Despite the manufacturer's product information reporting minimal systemic effects of topical tacrolim...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1002/phar.1418
データ提供:米国国立医学図書館(NLM)
Topical Tacrolimus: Understanding the Risk of Systemic Absorption
Topical tacrolimus, a medication used to treat cutaneous graft-versus-host disease (GVHD), is typically considered to have minimal systemic effects. However, this study presents two case reports of patients who developed toxic tacrolimus levels after using topical tacrolimus with occlusive dressings, highlighting the potential for increased systemic absorption in certain situations.Topical Tacrolimus and Occlusive Dressings: A Potential for Increased Systemic Absorption
The research found that the use of topical tacrolimus with occlusive dressings in patients with cutaneous GVHD can lead to increased systemic absorption and potentially toxic tacrolimus levels. These findings underscore the importance of monitoring tacrolimus levels in patients using topical tacrolimus, particularly when occlusive dressings are used. The study also suggests that factors such as skin permeability, skin barrier dysfunction, amount of body surface area treated, and use of occlusive dressings can influence the extent of systemic absorption.Managing Cutaneous GVHD: A Personalized Approach
This research highlights the importance of a personalized approach to managing cutaneous GVHD. It emphasizes the need for healthcare professionals to carefully consider the potential for increased systemic absorption when using topical tacrolimus, especially in patients with impaired skin barriers or when occlusive dressings are used. Close monitoring of tacrolimus levels and adjustments in treatment regimens may be needed to ensure safe and effective treatment outcomes.Dr. Camel's Conclusion
Just as a camel can be affected by the changing desert landscape, so too can our bodies respond to different medications and treatments. This research reminds us that even seemingly simple interventions, like the use of occlusive dressings, can have unexpected consequences. By remaining vigilant and adaptable, healthcare professionals can provide the best possible care for their patients, navigating the complexities of medication use and ensuring safe and effective outcomes. Let us continue to learn and grow, seeking to understand the subtle interactions between our bodies and the medications we use, striving to create a world where every individual receives the care they deserve.Date :
- Date Completed 2015-02-09
- Date Revised 2014-06-09
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.